دورة المؤشرنت للتحليل الفني
50 دينار كويتي
Gnbt منو يحدد اهدافه
- بادئ الموضوع circle
- تاريخ البدء
SMoOoKY
عضو نشط
يعني نصيحتكم يالربع نمسكه والله محد عافس محفظتي غيره :/
fesalll
عضو نشط
alisara قال:
شنو معناتها
alisara
عضو نشط
- التسجيل
- 4 نوفمبر 2005
- المشاركات
- 401
معناها أن الشركة سوف تلتزم بلوائح سوق الراسل بحيث أنها تلتزم بتقديم متطلبات السوق مثل الميزانيات والافصاح وغيرها من التزامات فتصبح الشركة أكثر ثقة وتحصل على تسهيلات وقروض لصرفها على عملها وهذا يؤدي الى أن بعض المحافظ والصناديق ممكن تدخل على الشركة لشراء أسهمها ولذلك نجد أن السهم اليوم ارتفع أكثر من 12%fesalll قال:
راعي العوده
عضو نشط
- التسجيل
- 18 يونيو 2003
- المشاركات
- 320
-------------alisara قال:
Generex Biotechnology (GNBT:Nasdaq - commentary - research - Cramer's Take) was sharply higher on word the company is scheduled to join the Russell Microcap Index later this month. The company's addition will take place when Russell Investment Group reconstitutes its family of U.S. indices on June 30, according to a preliminary membership list posted Friday.
"We believe that our inclusion in the Russell Microcap Index reflects the significant progress we have made in the past year in the development of drug delivery systems for the treatment and prevention of diabetes and avian influenza," the company said in a statement. Shares of Generex were gaining 27 cents, or 18.4%, to $1.74.
راعي العوده
عضو نشط
- التسجيل
- 18 يونيو 2003
- المشاركات
- 320
TARGET 2 Price: 2.1 Profit: 10.5% , Profit/Loss Ratio: 1.1 : 1 - Poor for an extreme rally
راعي العوده
عضو نشط
- التسجيل
- 18 يونيو 2003
- المشاركات
- 320
نزل خبر علي الشركة
TORONTO--(MARKET WIRE)--Jun 22, 2006 -- Generex Biotechnology Corporation (NasdaqSC:GNBT - News), a leader in the area of buccal drug delivery, announced today that it has entered into contractual arrangements with Cardinal Health, Inc. (NYSE:CAH - News), the leading provider of products and services supporting the health-care industry, to manufacture clinical trial batches of Generex Oral-lyn(TM), a proprietary oral insulin spray product.
ADVERTISEMENT
Under the terms of the contract, Cardinal Health will formulate and fill clinical trial batches of the canisters at its manufacturing and analytical services facility in Research Triangle Park, NC. Additional terms of the agreement were not disclosed.
Ranked No. 19 on the Fortune 500, Cardinal Health manufactures or packages products for nine out of the top 10 pharmaceutical companies and most leading biotechnology companies. The company manufactures or packages more than half a billion doses of pharmaceuticals every day.
TORONTO--(MARKET WIRE)--Jun 22, 2006 -- Generex Biotechnology Corporation (NasdaqSC:GNBT - News), a leader in the area of buccal drug delivery, announced today that it has entered into contractual arrangements with Cardinal Health, Inc. (NYSE:CAH - News), the leading provider of products and services supporting the health-care industry, to manufacture clinical trial batches of Generex Oral-lyn(TM), a proprietary oral insulin spray product.
ADVERTISEMENT
Under the terms of the contract, Cardinal Health will formulate and fill clinical trial batches of the canisters at its manufacturing and analytical services facility in Research Triangle Park, NC. Additional terms of the agreement were not disclosed.
Ranked No. 19 on the Fortune 500, Cardinal Health manufactures or packages products for nine out of the top 10 pharmaceutical companies and most leading biotechnology companies. The company manufactures or packages more than half a billion doses of pharmaceuticals every day.
دورة المؤشرنت للتحليل الفني
50 دينار كويتي